Stocks-CRON-Cronos Group Inc

CRON Cronos Group Inc

2.22 0.06 (2.78%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Stocks-CRON-Cronos Group Inc
CRON Cronos Group Inc
Trade

Overview

Prev Close 2.16
Day's Range 2.12 - 2.23
52 Week Range 1.68 - 3.11
Average Volume (3M) 938.36K
1-Year Return 15.54%
Beta1.4265
Market Cap 825.73M
P/E Ratio-14.33
Revenue101.78M
EPS-0.1507
Dividend (Yield) 0 (0%)
Sector
Health Technology
Industry
Pharmaceuticals Other
CEO
Michael Ryan Gorenstein
Employees
356

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Cronos Group Inc's revenues decreased by 5.07% and amounted to 87.24M. Net income increased by 58.25% to -70.44M. Net assets decreased by 3.93% to 1.10B and EPS increased from -0.45 to -0.19.
CRON's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
12.32%
Net Profit Margin
793.51%
Operating Margin
-66.25%
Return On Investment
2.58%
09/23
12/23
03/24
06/24
Total Revenue
24.81M
23.92M
25.29M
27.76M
Gross Profit
2.51M
1.38M
3.36M
5.28M
Operating Income
-20.35M
-18.17M
-13.89M
-15.01M
Net Income
-1.59M
-45.15M
-2.48M
-8.76M